Lipid-lowering drugs (statins), cholesterol, and coenzyme Q10. The Baycol case--a modern Pandora's box.
Bliznakov
E G
EG
Biomedical Research Consultants, Pompano Beach, Florida 33069, USA.
D002318:Cardiovascular Diseases / Q000517:prevention & control; D002784:Cholesterol / Q000378:metabolism*; D003067:Coenzymes; D004357:Drug Synergism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use; D011725:Pyridines / Q000009:adverse effects* / Q000627:therapeutic use; D012206:Rhabdomyolysis / Q000139:chemically induced; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards
D003067:Coenzymes; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; D014451:Ubiquinone; D002784:Cholesterol; C086276:cerivastatin; C024989:coenzyme Q10